Research ArticleOriginal Research
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting
Carmel Stober, Deepak R. Jadon, April W. Armstrong, Vinod Chandran, Maarten de Wit, Philip S. Helliwell, Philip J. Mease, Alexis Ogdie, Denis O’Sullivan, Stephen R. Pennington, Thorvardur Löve, Alberto Cauli, Leonieke van Mens, Robin Waxman, Jose U. Scher, Anne Barton, Christopher T. Ritchlin and Oliver FitzGerald
The Journal of Rheumatology Supplement June 2021, 97 4-9; DOI: https://doi.org/10.3899/jrheum.201667
Carmel Stober
1C. Stober, MBChB, MRCP, PhD, MSc, Department of Medicine, University of Cambridge, Cambridge, UK;
MBChB, MRCP, PhD, MScDeepak R. Jadon
2D.R. Jadon, MBBCh, MRCP, PhD, University of Cambridge, Cambridge, UK;
MBBCh, MRCP, PhDApril W. Armstrong
3A.W. Armstrong, MD, PhD, Professor of Dermatology, Associate Dean for Clinical Research, Director of Clinical Research Support, Southern California Clinical and Translational Science Institute (SC CTSI), Vice Chair Director, Clinical Trials and Outcomes Research Director, Psoriasis Program, Department of Dermatology, Keck School of Medicine at USC, University of Southern California, Los Angeles, California, USA;
MD, PhDVinod Chandran
4V. Chandran, MD, DM, PhD, Department of Medicine, Division of Rheumatology, University of Toronto, Toronto Western Hospital, Krembil Research Institute, Toronto, Ontario, Canada;
MD, DM, PhDMaarten de Wit
5M. de Wit, PhD, GRAPPA Patient Research Partner, Department of Medical Humanities, Amsterdam University Medical Centre, Amsterdam, the Netherlands;
PhDPhilip S. Helliwell
6P.S. Helliwell, MD, PhD Professor of Clinical Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, NIHR Leeds Biomedical Research Centre, Leeds, UK;
MD, PhDPhilip J. Mease
7P.J. Mease, MD, Rheumatology Research, Swedish Medical Center/Providence St. Joseph Health and University of Washington School of Medicine, Seattle, Washington, USA;
MDAlexis Ogdie
8A. Ogdie, MD, MSCE, Associate Professor of Medicine and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA;
MD, MSCEDenis O’Sullivan
9D. O’Sullivan, BE, GRAPPA Patient Research Partner, Our Lady’s Hospice & Care Services, Rheumatic & Musculoskeletal Disease Unit, Dublin, Ireland;
BEStephen R. Pennington
10S.R. Pennington, PhD, School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Ireland;
PhDThorvardur Löve
11T. Löve, MD, PhD, Faculty of Medicine, University of Iceland, and Department of Research, Landspitali University Hospital, Reykjavik, Iceland;
MD, PhDAlberto Cauli
12A. Cauli, MD, PhD, Rheumatology Unit, University Clinic and AOU of Cagliari, Monserrato, Italy;
MD, PhDLeonieke van Mens
13L. van Mens, MD, PhD, Amsterdam University Medical Centers/University of Amsterdam, Department of Clinical Immunology and Rheumatology Amsterdam, Infection & Immunity Institute, Amsterdam, the Netherlands;
MD, PhDRobin Waxman
14R. Waxman, MPH, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Harehills Lane, Leeds, and NIHR Leeds Biomedical Research Centre, Leeds, UK;
MPHJose U. Scher
15J.U. Scher, MD, Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA;
MDAnne Barton
16A. Barton, MBChB, MSc, PhD, FRCP, Centre for Musculoskeletal Research, The University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester University NHS Trust, Manchester, UK;
MBChB, MSc, PhD, FRCPChristopher T. Ritchlin
17C.T. Ritchlin, MD, MPH, Professor of Medicine, Division of Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA;
MD, MPHOliver FitzGerald
18O. FitzGerald, MD, FRCPI, FRCP, Consultant Rheumatologist and Newman Clinical Research Professor, Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland.
MD, FRCPI, FRCPPublished eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting
Carmel Stober, Deepak R. Jadon, April W. Armstrong, Vinod Chandran, Maarten de Wit, Philip S. Helliwell, Philip J. Mease, Alexis Ogdie, Denis O’Sullivan, Stephen R. Pennington, Thorvardur Löve, Alberto Cauli, Leonieke van Mens, Robin Waxman, Jose U. Scher, Anne Barton, Christopher T. Ritchlin, Oliver FitzGerald
The Journal of Rheumatology Supplement Jun 2021, 97 4-9; DOI: 10.3899/jrheum.201667
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting
Carmel Stober, Deepak R. Jadon, April W. Armstrong, Vinod Chandran, Maarten de Wit, Philip S. Helliwell, Philip J. Mease, Alexis Ogdie, Denis O’Sullivan, Stephen R. Pennington, Thorvardur Löve, Alberto Cauli, Leonieke van Mens, Robin Waxman, Jose U. Scher, Anne Barton, Christopher T. Ritchlin, Oliver FitzGerald
The Journal of Rheumatology Supplement Jun 2021, 97 4-9; DOI: 10.3899/jrheum.201667
Jump to section
- Article
- Abstract
- Goals for the GRAPPA-CRN 2020 Annual Meeting
- Keynote Lecture
- Update on the Pilot Project/Investigator-initiated Study
- Update on Biomarkers as Predictors of structural DAMage in PsA (BioDAM PsA) Study
- Update on PreventPsA: Evaluating Biomarkers of the Development of PsA among Patients With Psoriasis (PsC)
- Update on PredictORPsA (Predicting Treatment RespOnse in patients with EaRly PsA): Identifying Biomarkers
- Update on Innovative Medicines Initiative (IMI) Application
- Update on Accelerated Medicines Partnership (AMP) Psoriatic Disease Spectrum
- Summary
- Future Directions
- Footnotes
- References
- Info & Metrics
- References
- eLetters